Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness - Wisconsin, October 2022-February 2023

被引:0
|
作者
McLean, Huong Q. [1 ]
Petrie, Joshua G. [1 ]
Hanson, Kayla E. [1 ]
Meece, Jennifer K. [1 ]
Rolfes, Melissa A. [2 ]
Sylvester, Gregg C. [3 ]
Neumann, Gabriele [4 ]
Kawaoka, Yoshihiro [4 ]
Belongia, Edward A. [1 ]
机构
[1] Marshfield Clin Res Inst, Marshfield 54449, WI USA
[2] Natl Ctr Immunizat & Resp Dis CDC, Influenza Div, Marshfield, WI USA
[3] CSL Seqirus, Summit, NJ USA
[4] Univ Wisconsin Madison, Sch Vet Med, Dept Pathobiol Sci, Madison, WI USA
来源
关键词
UNITED-STATES;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [41] Establishment of Reference Reagents for Single-Radial-Immunodiffusion Assay on the 2022/23 Seasonal Influenza Vaccine in Japan and Their Quality Validation
    Shimasaki, Noriko
    Kuwahara, Tomoko
    Nishijima, Haruna
    Nakamura, Kazuya
    Sato, Kayoko
    Murano, Keiko
    Itamura, Shigeyuki
    Akahori, Yukiko
    Takashita, Emi
    Kishida, Noriko
    Arita, Tomoko
    Nakauchi, Mina
    Takeda, Makoto
    Hasegawa, Hideki
    Ryo, Akihide
    Harada, Yuichi
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2024, 77 (02) : 105 - 111
  • [42] Influenza vaccine effectiveness in preventing hospital encounters for laboratory-confirmed infection among Italian adults, 2022/23 season
    Domnich, Alexander
    Orsi, Andrea
    Ogliastro, Matilde
    Trombetta, Carlo-Simone
    Scarpaleggia, Marianna
    Stefanelli, Federica
    Panatto, Donatella
    Bruzzone, Bianca
    Icardi, Giancarlo
    VACCINE, 2023, 41 (33) : 4861 - 4866
  • [43] Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016
    Chambers, C.
    Skowronski, D. M.
    Sabaiduc, S.
    Winter, A. L.
    Dickinson, J. A.
    De Serres, G.
    Gubbay, J. B.
    Drews, S. J.
    Martineau, C.
    Eshaghi, A.
    Krajden, M.
    Bastien, N.
    Li, Y.
    EUROSURVEILLANCE, 2016, 21 (11): : 27 - 34
  • [44] Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
    Skowronski, Danuta M.
    Zou, Macy
    Sabaiduc, Suzana
    Murti, Michelle
    Olsha, Romy
    Dickinson, James A.
    Gubbay, Jonathan B.
    Croxen, Matthew A.
    Charest, Hugues
    Jassem, Agatha
    Krajden, Mel
    Bastien, Nathalie
    Li, Yan
    De Serres, Gaston
    EUROSURVEILLANCE, 2020, 25 (07) : 2 - 8
  • [45] Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023
    Tenforde, Mark W.
    Weber, Zachary A.
    Yang, Duck-Hye
    DeSilva, Malini B.
    Dascomb, Kristin
    Irving, Stephanie A.
    Naleway, Allison L.
    Gaglani, Manjusha
    Fireman, Bruce
    Lewis, Ned
    Zerbo, Ousseny
    Goddard, Kristin
    Timbol, Julius
    Hansen, John R.
    Grisel, Nancy
    Arndorfer, Julie
    McEvoy, Charlene E.
    Essien, Inih J.
    Rao, Suchitra
    Grannis, Shaun J.
    Kharbanda, Anupam B.
    Natarajan, Karthik
    Ong, Toan C.
    Embi, Peter J.
    Ball, Sarah W.
    Dunne, Margaret M.
    Kirshner, Lindsey
    Wiegand, Ryan E.
    Dickerson, Monica
    Patel, Palak
    Ray, Caitlin
    Flannery, Brendan
    Garg, Shikha
    Adams, Katherine
    Klein, Nicola P.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 230 (01): : 141 - 151
  • [46] Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
    Skowronski, Danuta M.
    Chuangl, Erica S. Y.
    Sabaiducl, Suzana
    Kaweskil, Samantha E.
    Kiml, Shinhye
    Dickinson, James A.
    Olshae, Romy
    Gubbay, Jonathan B.
    Zelyase, Nathan
    Charest, Hugues
    Bastiene, Nathalie
    Jassem, Agatha N.
    De Serres, Gaston
    EUROSURVEILLANCE, 2023, 28 (05)
  • [47] Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023
    Chung, Jessie R.
    Shirk, Philip
    Gaglani, Manjusha
    Mutnal, Manohar B.
    Nowalk, Mary Patricia
    Geffel, Krissy Moehling
    House, Stacey L.
    Curley, Tara
    Wernli, Karen J.
    Kiniry, Erika L.
    Martin, Emily T.
    Vaughn, Ivana A.
    Murugan, Vel
    Lim, Efrem S.
    Saade, Elie
    Faryar, Kiran
    Williams, Olivia L.
    Walter, Emmanuel B.
    Price, Ashley M.
    Barnes, John R.
    DaSilva, Juliana
    Kondor, Rebecca
    Ellington, Sascha
    Flannery, Brendan
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (06)
  • [48] Interim seasonal influenza vaccine effectiveness estimates as proxy for final estimates: analysis of systematically identified matched pairs of interim/final estimates from test-negative design studies in outpatient settings from 2010/11 to 2018/19
    Okoli, George N.
    Abdulwahid, Tiba
    Racovitan, Florentin
    Righolt, Christiaan H.
    Mahmud, Salaheddin M.
    EXPERT REVIEW OF VACCINES, 2021, 20 (05) : 585 - 599
  • [49] Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years-Increasing Community Access to Testing Program, United States, July 2022-February 2023
    Fleming-Dutra, Katherine E.
    Ciesla, Allison Avrich
    Roper, Lauren E.
    Smith, Zachary R.
    Miller, Joseph D.
    Accorsi, Emma K.
    Verani, Jennifer R.
    Shang, Nong
    Derado, Gordana
    Wiegand, Ryan E.
    Pilishvili, Tamara
    Britton, Amadea
    Link-Gelles, Ruth
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (07): : 177 - 182
  • [50] Influenza Vaccine Effectiveness against Influenza A-Associated Outpatient and Emergency-Department-Attended Influenza-like Illness during the Delayed 2022-2023 Season in Beijing, China
    Zhang, Li
    Lu, Guilan
    Ma, Chunna
    Zhang, Jiaojiao
    Li, Jia
    Duan, Wei
    Ma, Jiaxin
    Shi, Weixian
    Wang, Yingying
    Sun, Ying
    Zhang, Daitao
    Wang, Quanyi
    Huo, Da
    VACCINES, 2024, 12 (10)